[ Tickers Inside ] Tomorrow's 7 Best Dividend Stocks

This is a must read. [View it in your browser.]( [Divider] [fmn-editor header.jpg] --------------------------------------------------------------- [Soldiers Carry 20 Pounds of Lithium Batteries?]( [See Who Could Benefit From This Stunning Lithium Opportunity]( --------------------------------------------------------------- February 23, 2022 Dear Reader, We have identified several stocks which are expected to go “Ex-Dividend” very soon. If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend. If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. So please keep this in mind. Below is our latest Dividend Report: --------------------------------------------------------------- [All Electric Commitment From GM, Volkswagen, Could Put Lithium Stock In A Supercycle]( automakers are pledging to go "fully electric" by 2035. NOW is the perfect time to get in on the "EV Revolution." And the best way to potentially do that, is to skip over the overvalued electric vehicle stocks... [And Look At Under-The-Radar Lithium Companies...Like This One]( --------------------------------------------------------------- [Analog Devices]( Symbol: [ADI]( Recent Price: $160.88 Average Analyst Price Target: $205.31 (27.62%) Market Cap: $84.19B Expected Ex-Dividend Date: Feb 24 2022 Expected Payment Date: Mar 08 2022 Expected Dividend & Yield: 1.76% Recent Analyst Action: Ross Seymore, analyst at Deutsche Bank, reiterates coverage on [Analog Devices (ADI)]( in the Technology sector with a Hold rating and a price target of $185 (6 days ago). [TipRanks.com]( also reports that [Analog Devices]( currently has 16 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $205.31 . The target pricing ranges from a high forecast of $225.00 down to a low forecast of $180.00. [Analog Devices (ADI)]( last closing price was $160.88 which would put the average price target at 27.62% upside. Here are 3rd party ratings for [ADI]( - TipRanks.com: Strong Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Buy, Top 8% (21 out of 248) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [He broke the biggest rule in options investing.... then retired with $5.3 million]( He broke the biggest rule in options investing…and retired at 37 with more than $5.3m in the bank… Now, for the first time- Jim Fink has agreed to reveal his personal Options trading “Blueprint.” The unique twist in his strategy could hand you an extra $67,548- [Get the full details here]( --------------------------------------------------------------- [Baxter International]( Symbol: [BAX]( Recent Price: $84.46 Average Analyst Price Target: $96.67 (14.46%) Market Cap: $42.29B Expected Ex-Dividend Date: Feb 24 2022 Expected Payment Date: Apr 01 2022 Expected Dividend & Yield: 1.36% Recent Analyst Action: Rick Wise, analyst at Stifel Nicolaus, reiterates coverage on [Baxter International (BAX)]( in the Healthcare sector with a Buy rating and a price target of $91 (2 days ago). [TipRanks.com]( also reports that [Baxter International]( currently has 12 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $96.67 . The target pricing ranges from a high forecast of $105.00 down to a low forecast of $91.00. [Baxter International (BAX)]( last closing price was $84.46 which would put the average price target at 14.46% upside. Here are 3rd party ratings for [BAX]( - TipRanks.com: Strong Buy - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Bottom 26% (183 out of 248) [Click for chart >>]( -------------------------------------------------------------------------- [CDW]( Symbol: [CDW]( Recent Price: $177.99 Average Analyst Price Target: $221.20 (24.28%) Market Cap: $24.16B Expected Ex-Dividend Date: Feb 24 2022 Expected Payment Date: Mar 10 2022 Expected Dividend & Yield: 0.99% Recent Analyst Action: Kathryn Huberty, analyst at Morgan Stanley, reiterates coverage on [CDW (CDW)]( in the Technology sector with a Hold rating and a price target of $201 (1 week ago). [TipRanks.com]( also reports that [CDW]( currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $221.20 . The target pricing ranges from a high forecast of $250.00 down to a low forecast of $200.00. [CDW (CDW)]( last closing price was $177.99 which would put the average price target at 24.28% upside. Here are 3rd party ratings for [CDW]( - TipRanks.com: Moderate Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: sell - Zacks.com: Buy, Bottom 42% (143 out of 248) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [George Gilder: "Do NOT buy bitcoin until you've seen this."]( George believes something bigger – and potentially more lucrative – than bitcoin is emerging as we speak. It could ultimately transform the Internet and the world monetary system. And George recently went on camera to discuss his top stocks to buy to tap into that trillion-dollar potential. [Check the footage out HERE while you can.]( --------------------------------------------------------------- [Chemours Company]( Symbol: [CC]( Recent Price: $28.61 Average Analyst Price Target: $40.14 (40.30%) Market Cap: $4.58B Expected Ex-Dividend Date: Feb 24 2022 Expected Payment Date: Mar 15 2022 Expected Dividend & Yield: 3.42% Recent Analyst Action: Arun Viswanathan, analyst at RBC Capital, reiterates coverage on [Chemours Company (CC)]( in the Basic Materials sector with a Buy rating and a price target of $41 (1 week ago). [TipRanks.com]( also reports that [Chemours Company]( currently has 7 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $40.14 . The target pricing ranges from a high forecast of $53.00 down to a low forecast of $30.00. [Chemours Company (CC)]( last closing price was $28.61 which would put the average price target at 40.30% upside. Here are 3rd party ratings for [CC]( - TipRanks.com: Moderate Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Bottom 42% (143 out of 248) [Click for chart >>]( -------------------------------------------------------------------------- [Evercore Partners]( Symbol: [EVR]( Recent Price: $119.31 Average Analyst Price Target: $160.50 (34.52%) Market Cap: $4.66B Expected Ex-Dividend Date: Feb 24 2022 Expected Payment Date: Mar 11 2022 Expected Dividend & Yield: 2.25% Recent Analyst Action: Steven Chubak, analyst at Wolfe Research, reiterates coverage on [Evercore Partners (EVR)]( in the Financial sector with a Buy rating and a price target of $172 (2 weeks ago). [TipRanks.com]( also reports that [Evercore Partners]( currently has 7 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $160.50 . The target pricing ranges from a high forecast of $180.00 down to a low forecast of $141.00. [Evercore Partners (EVR)]( last closing price was $119.31 which would put the average price target at 34.52% upside. Here are 3rd party ratings for [EVR]( - TipRanks.com: Moderate Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 21% (53 out of 248) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Sacrificing Safety for Decent Yields? Do This Instead...]( Some accept crazy-low yields for safety. Others sacrifice safety for high yields. But did you know you can find BOTH high returns AND relative safety in one place? Say goodbye to banks and Wall Street brokers. And tell the Fed to go jump in the lake. For the first-ever, real-money demonstration of an income opportunity that’s virtually out of this world... [Go here for immediate access.]( --------------------------------------------------------------- [Fortune Brands]( Symbol: [FBHS]( Recent Price: $86.28 Average Analyst Price Target: $116.33 (34.83%) Market Cap: $11.71B Expected Ex-Dividend Date: Feb 24 2022 Expected Payment Date: Mar 16 2022 Expected Dividend & Yield: 1.19% Recent Analyst Action: Michael Rehaut, analyst at J.P. Morgan, reiterates coverage on [Fortune Brands (FBHS)]( in the Industrial Goods sector with a Buy rating and a price target of $123 (2 weeks ago). [TipRanks.com]( also reports that [Fortune Brands]( currently has 6 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $116.33 . The target pricing ranges from a high forecast of $130.00 down to a low forecast of $100.00. [Fortune Brands (FBHS)]( last closing price was $86.28 which would put the average price target at 34.83% upside. Here are 3rd party ratings for [FBHS]( - TipRanks.com: Moderate Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 25% (63 out of 248) [Click for chart >>]( -------------------------------------------------------------------------- [Honeywell International]( Symbol: [HON]( Recent Price: $182.56 Average Analyst Price Target: $226.27 (23.94%) Market Cap: $125.20B Expected Ex-Dividend Date: Feb 24 2022 Expected Payment Date: Mar 11 2022 Expected Dividend & Yield: 2.10% Recent Analyst Action: Markus Mittermaier, analyst at UBS, reiterates coverage on [Honeywell International (HON)]( in the Industrial Goods sector with a Buy rating and a price target of $220 (1 week ago). [TipRanks.com]( also reports that [Honeywell International]( currently has 15 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $226.27 . The target pricing ranges from a high forecast of $248.00 down to a low forecast of $205.00. [Honeywell International (HON)]( last closing price was $182.56 which would put the average price target at 23.94% upside. Here are 3rd party ratings for [HON]( - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Top 41% (102 out of 248) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Economic and National Security Threats Create Lithium Bonanza]( U.S. and China are fighting for new sources of lithium – the linchpin of clean energy. Lithium mining operations have been declared a national emergency. Biden has ordered America's lithium supply chain to be strengthened and investors in lithium exploration companies are rejoicing. We may be entering a decades-long lithium bull run. You don't want to miss it. [Click here for the full story.]( --------------------------------------------------------------- And there you have it... Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend. If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information. [Divider] MarketSectorMovers.com | PO Box 407, Mt. Mourne, NC 28123 This is email was sent to {EMAIL} as part of your free newsletter subscription, [click here to unsubscribe](. Copyright © 2020 WallStreetSectors.com All rights reserved. This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.